10/27/2021 « Cenexi: the ideal partner for sterile filling » A promising title for Cenexi, in The Parmaceutical Post magazine from October 2021. In the dossier on Challenges of new therapies, Cenexi sets out its innovation momentum on page 68, driven by Crossject and Ose Immunotherapeutics projects. This article follows an interview with President Christophe DURAND. The 100-pages magazine available by subscription in its paper version is also accessible by downloading the PDF in the link below. Enjoy your reading! THE ARTICLE ABOUT CENEXI IN PAGE 68 READ THE WHOLE MAGAZINE Other articles 10/19/2021 Cenexi will be at CPHI Worldwide – from November 9th to 11th 2021, in Milan 06/30/2021 OSE IMMUNOTHERAPEUTICS announces manufacturing agreement with CENEXI for clinical batches … 05/28/2021 (FR) Cenexi and Crossject strengthen their partnership to ensure the ramp-up of industrial… BACK TO TOP CENEXI HEADQUARTERS 52, rue Marcel et Jacques Gaucher 94120 Fontenay-sous-Bois France +33 1 43 94 88 00 BRAINE L’ALLEUD Rue de la Papyrée 2-6 1420 Braine l’Alleud Belgium +32 2 386 13 01 OSNY 17, rue de Pontoise 95520 Osny France +33 1 34 20 44 20 HÉROUVILLE-SAINT-CLAIR 2 rue Louis Pasteur 14200 Hérouville-Saint-Clair France +33 2 31 06 92 00 Ⓒ 2020 Cenexi All Rights Reserved. Legal Terms Création This site uses cookies and gives you control over what you want to activate OK, accept all Deny all cookies Personalize